| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |